We are live on ! Find out more
SGMO

SANGAMO THERAPEUTICS INC
SGMO

Delisted

SGMO was delisted on the 4th of May, 2026.

Back to rankings

210 hedge funds and large institutions have $767M invested in SANGAMO THERAPEUTICS INC in 2020 Q3 according to their latest regulatory filings, with 32 funds opening new positions, 55 increasing their positions, 69 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

29% more call options, than puts

Call options by funds: $14.1M | Put options by funds: $11M

28% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 25

11% more capital invested

Capital invested by funds: $691M → $767M (+$76.4M)

3.17% more ownership

Funds ownership: 54.73% → 57.9% (+3.2%)

2% more funds holding

Funds holding: 205 → 210 (+5)

20% less repeat investments, than reductions

Existing positions increased: 55 | Existing positions reduced: 69

Holders
210
Holders Change
+5
Holders Change %
+2.44%
% of All Funds
4.24%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
32
Increased
55
Reduced
69
Closed
25
Calls
$14.1M
Puts
$11M
Net Calls
+$3.14M
Net Calls Change
-$1.82M

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$14.3M
2
Citadel Advisors
Citadel Advisors
Florida
+$10.7M
3
N
Nuveen
North Carolina
+$7.17M
4
Invesco
Invesco
Georgia
+$6.08M
5
Millennium Management
Millennium Management
New York
+$5.96M

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$4.91M
2
CC
Casdin Capital
New York
-$4.06M
3
Two Sigma Investments
Two Sigma Investments
New York
-$3.74M
4
Vanguard Group
Vanguard Group
Pennsylvania
-$3.74M
5
Nordea Investment Management
Nordea Investment Management
Sweden
-$3.54M
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
26
Fidelity Investments
Massachusetts
$7.2M -$720K -66,600 -8%
UBS AM
27
UBS AM
Illinois
$7.15M +$70.5K +6,520 +0.9%
RPAM
28
Rhenman & Partners Asset Management
Sweden
$6.38M – – –
Invesco
29
Invesco
Georgia
$5.87M +$6.08M +562,474 +967%
Bank of New York Mellon
30
Bank of New York Mellon
New York
$5M -$157K -14,534 -3%
PAM
31
Panagora Asset Management
Massachusetts
$4.58M +$194K +17,955 +4%
Hudson Bay Capital Management
32
Hudson Bay Capital Management
Connecticut
$4.54M -$433K -40,000 -8%
AGA
33
Altrinsic Global Advisors
Connecticut
$3.94M – – –
Macquarie Group
34
Macquarie Group
Australia
$3.79M -$35K -3,237 -0.8%
B
35
Bailard
California
$3.5M -$377K -34,900 -9%
CS
36
Candriam SCA
Luxembourg
$3.5M – – –
Barclays
37
Barclays
United Kingdom
$3.31M +$146K +13,533 +4%
Nordea Investment Management
38
Nordea Investment Management
Sweden
$3.28M -$3.54M -327,537 -50%
Morgan Stanley
39
Morgan Stanley
New York
$3.17M -$693K -64,099 -16%
Assenagon Asset Management
40
Assenagon Asset Management
Luxembourg
$3.14M +$3.6M +332,611 New
Susquehanna International Group
41
Susquehanna International Group
Pennsylvania
$3.13M -$1.4M -129,621 -28%
PP
42
PDT Partners
New York
$3.02M +$1.68M +155,407 +94%
Bank of Montreal
43
Bank of Montreal
Ontario, Canada
$2.85M +$3.03M +280,211 +1,965%
Bank of America
44
Bank of America
North Carolina
$2.7M +$465K +43,023 +18%
Swiss National Bank
45
Swiss National Bank
Switzerland
$2.56M +$136K +12,600 +5%
California Public Employees Retirement System
46
California Public Employees Retirement System
California
$2.27M +$76.8K +7,100 +3%
PPA
47
Parametric Portfolio Associates
Washington
$2.19M +$239K +22,104 +11%
PIM
48
Platinum Investment Management
Australia
$2.06M -$240K -22,176 -9%
Deutsche Bank
49
Deutsche Bank
Germany
$1.93M -$2.67M -247,078 -55%
FCM
50
Frontier Capital Management
Massachusetts
$1.91M -$186K -17,152 -8%
1
2
3 4 5

SGMO Hedge Fund Activity: Q3 2020 in Review

210 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in SANGAMO THERAPEUTICS INC (SGMO) for Q3 2020, worth a combined $767M — up 11% from $691M a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new SGMO positions and 25 closed out — a net gain of 7 holders — while 55 added to existing stakes and 69 trimmed.

The largest buyer was Renaissance Technologies, opening a new position worth an estimated $14.3M. The largest seller was BlackRock, cutting an estimated $4.91M.

  • 210 institutional investors held SANGAMO THERAPEUTICS INC (SGMO) as of Q3 2020, up from 205 in Q2 2020.
  • Funds reported $767M of SANGAMO THERAPEUTICS INC stock for Q3 2020, up 11% quarter-over-quarter.
  • 32 funds opened new SANGAMO THERAPEUTICS INC positions in Q3 2020 and 25 closed out, a net change of +7 holders.
  • The largest SANGAMO THERAPEUTICS INC buyer in Q3 2020 was Renaissance Technologies, an estimated $14.3M added.
  • The largest SANGAMO THERAPEUTICS INC seller in Q3 2020 was BlackRock, an estimated $4.91M sold.

Based on aggregated 13F filings for Q3 2020.